Back to Search Start Over

Transcriptomic profiling of a late recurrent nuclear protein in testis carcinoma of the lung 14 years after the initial operation: a case report.

Authors :
Kato T
Oyamatsu H
Hanamatsu Y
Huang H
Okado S
Imamura Y
Nomata Y
Watanabe H
Kadomatsu Y
Ueno H
Nakamura S
Mizuno T
Hase T
Takeuchi T
Chen-Yoshikawa TF
Source :
Translational lung cancer research [Transl Lung Cancer Res] 2024 Jul 30; Vol. 13 (7), pp. 1756-1762. Date of Electronic Publication: 2024 Jul 11.
Publication Year :
2024

Abstract

Background: Nuclear protein in testis (NUT) carcinoma (NC) of the lung is a rare cancer that occurs mainly in young adolescents and adults. NC is genetically characterized by NUTM1 rearrangements, which usually take the form of BRD4-NUT fusions. The prognosis for NC is dismal, and treatment with conventional chemotherapeutic regimens is ineffective.<br />Case Description: We herein describe the case of a 53-year-old woman with recurrent NC of the lung 14 years after surgery for nasal cavity cancer. Chest computed tomography revealed a 5.5-cm tumor in the lower lobe of the left lung. We completely resected the recurrent lung NC via thoracotomy. Immunohistochemistry (IHC) of the lung and nasal cavity cancers showed diffuse strong expression of NUT. RNA-seq of the lung NC revealed NUTM1 rearrangement, with a fusion of BRD4 exon 10 to NUTM1 exon 4. This breakpoint has never been reported before. In addition, IHC revealed elevated expression of parathyroid hormone-like hormone in the lung NC but not in the nasal cavity NC, indicating that the lung and nasal cavity NCs were metachronous multiple primary cancers.<br />Conclusions: We experienced a rare recurrence of lung NC 14 years after the initial surgery. The BRD4-NUT fusion consisted of a new breakpoint. Furthermore, the expression pattern of parathyroid hormone-like hormone ( PTHLH ) suggested that the NCs in the nasal cavity and lung may be metachronous multiple lung cancers. This extremely rare case highlighted the possibility of identifying less malignant NCs in patients with poorly differentiated tumors via fusion gene analysis and the need to develop more effective treatment strategies for this malignancy.<br />Competing Interests: Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tlcr.amegroups.com/article/view/10.21037/tlcr-24-259/coif). The authors have no conflicts of interest to declare.<br /> (2024 Translational Lung Cancer Research. All rights reserved.)

Details

Language :
English
ISSN :
2218-6751
Volume :
13
Issue :
7
Database :
MEDLINE
Journal :
Translational lung cancer research
Publication Type :
Academic Journal
Accession number :
39118893
Full Text :
https://doi.org/10.21037/tlcr-24-259